Department of Hematology and Oncology, University Hospital of Heidelberg, Heidelberg, Germany.
Department of Radiology, German Cancer Research Center, Heidelberg, Germany.
Blood Cancer J. 2017 Aug 25;7(8):e599. doi: 10.1038/bcj.2017.78.
For decades, conventional skeletal survey (CSS) has been the standard imaging technique for multiple myeloma (MM). However, recently whole-body computed tomography (WBCT) has been implemented into the diagnostic criteria of MM. This analysis compares sensitivity and prognostic significance of WBCT and CSS in patients with smoldering MM (SMM) and MM. Fifty-four of 212 patients (25.5%) had a negative CSS and a positive WBCT for osteolytic lesions (P<0.0001). Of 66 patients with SMM based on CSS, 12 (22.2%) had osteolytic lesions on WBCT. In comparison, WBCT failed to detect some bone destructions in the appendicular skeleton possibly due to limitations of the field of view. Presence of lytic bone lesions in WBCT was of borderline prognostic significance (P=0.051) for SMM patients, with a median time to progression of 38 versus 82 months for those without bone destructions. In conclusion, WBCT identifies significantly more sites of bone destruction than CSS. More than 20% of patients with SMM according to CSS have in fact active MM detectable with WBCT. On the basis of this and other studies, WBCT (either computed tomography (CT) alone or as part of a positron emission tomography-CT protocol) should be considered the current standard for the detection of osteolytic lesions in MM.
几十年来,传统的全身骨骼检查(CSS)一直是多发性骨髓瘤(MM)的标准影像学检查技术。然而,最近全身计算机断层扫描(WBCT)已被纳入 MM 的诊断标准。本分析比较了冒烟型多发性骨髓瘤(SMM)和 MM 患者中 WBCT 和 CSS 的敏感性和预后意义。在 212 例患者中,54 例(25.5%)CSS 阴性而 WBCT 阳性存在溶骨性病变(P<0.0001)。在基于 CSS 的 66 例 SMM 患者中,12 例(22.2%)在 WBCT 上存在溶骨性病变。相比之下,WBCT 可能由于视野限制而未能检测到四肢骨骼的一些骨质破坏。WBCT 存在溶骨性骨病变对 SMM 患者具有边界预后意义(P=0.051),无骨质破坏的患者中位进展时间为 38 个月,而有骨质破坏的患者为 82 个月。总之,WBCT 比 CSS 识别出更多的骨破坏部位。根据 CSS,超过 20%的 SMM 患者实际上存在可通过 WBCT 检测到的活动性 MM。基于这一研究和其他研究,WBCT(单独 CT 或作为正电子发射断层扫描-CT 方案的一部分)应被视为 MM 溶骨性病变检测的当前标准。
Cancers (Basel). 2020-2-19
Radiologe. 2014-6
Cancer Pathog Ther. 2024-12-18
Lancet Reg Health West Pac. 2025-6-7
J Bone Oncol. 2025-4-1
Diagnostics (Basel). 2025-1-18
Cancers (Basel). 2024-12-7
Am Soc Clin Oncol Educ Book. 2016
Lancet Oncol. 2014-10-26